Florence Coste
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Florence Coste has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah Mohammed Asiri
College of Medicine, Alfaisal University, Riyadh 11533, Saudi Arabia
1 shared publication - Abrar Alasmari
Population Health Deputyship, Saudi Arabia Ministry of Health, Riyadh, Saudi Arabia
1 shared publication - Alp Dogu
Sanofi Vaccines, Medical Affairs, Sanofi, Dubai, United Arab Emirates
1 shared publication - Anas Khan
Emergency and Disaster Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia
1 shared publication - Angie Upegui
Sanofi Vaccines, Health Economics and Value Assessment, Sanofi, Lyon, France
1 shared publication - George Wahba
Sanofi Vaccines, Medical Affairs, Sanofi, Dubai, United Arab Emirates
1 shared publication
Latest Publications
- Open Access
- 28 August 2026
- Published by Springer Nature in Infectious Diseases and Therapy
- Vol. 15 (11) , 2957-2975
Mass Gatherings as Amplifiers of Meningococcal Disease: A Modeling Study of Hajj and Umrah
- 28 August 2026
- Published by Springer Nature in Infectious Diseases and Therapy
- Vol. 15 (11) , 2957-2975
Open AccessMass Gatherings as Amplifiers of Meningococcal Disease: A Modeling Study of Hajj and Umrah
- Open Access
- 26 September 2023
- Published by Springer Nature in Infectious Diseases and Therapy
- Vol. 12 (10) , 2337-2351
Range of Clinical Manifestations Caused by Invasive Meningococcal Disease Due to Serogroup W: A Systematic Review
Introduction Invasive meningococcal disease (IMD) due to serogroup W meningococci (MenW) is consistently reported with atypical clinical manifestations, including gastrointestinal symptoms, bacteremic pneumonia, and septic arthritis. We undertook a systematic review of the literature for a comprehensive assessment of the clinical presentation of IMD caused by MenW. Methods PubMed and Embase databases were searched from inception to June 2022 using a combination of MeSH terms and free text for articles that reported symptoms and signs of MenW IMD, and associated manifestations. Results The most commonly reported symptoms identified included: fever (range 36–100% of cases), nausea and/or vomiting (range 38–47%), vomiting (range 14–68%), cough (range 7–57%), sore throat (range 13–34%), headache (range 7–50%), diarrhea (range 8–47%), altered consciousness/mental status (range 7–38%), stiff neck (range 7–54%), and nausea (range 7–20%). Sepsis (range 15–83% of cases) was the most commonly reported manifestation followed by meningitis (range 5–72%), sepsis and meningitis (range 6–74%), bacteremic pneumonia (range 4–24%), arthritis (range 1–15%), and other manifestations (e.g., pharyngitis/epiglottitis/supraglottitis/tonsillitis/conjunctivitis; range 1–24%). The case fatality rates ranged from 8–40%, and among the survivors 4–14% had long-term sequelae. Conclusions Clinicians need to be aware of the nonspecific symptoms and signs of IMD, as well as of the atypical manifestations in regions where MenW is known to circulate to ensure timely diagnoses and treatment.
- 26 September 2023
- Published by Springer Nature in Infectious Diseases and Therapy
- Vol. 12 (10) , 2337-2351
Open AccessRange of Clinical Manifestations Caused by Invasive Meningococcal Disease Due to Serogroup W: A Systematic Review
Introduction Invasive meningococcal disease (IMD) due to serogroup W meningococci (MenW) is consistently reported with atypical clinical manifestations, including gastrointestinal symptoms, bacteremic pneumonia, and septic arthritis. We undertook a systematic review of the literature for a comprehensive assessment of the clinical presentation of IMD caused by MenW. Methods PubMed and Embase databases were searched from inception to June 2022 using a combination of MeSH terms and free text for articles that reported symptoms and signs of MenW IMD, and associated manifestations. Results The most commonly reported symptoms identified included: fever (range 36–100% of cases), nausea and/or vomiting (range 38–47%), vomiting (range 14–68%), cough (range 7–57%), sore throat (range 13–34%), headache (range 7–50%), diarrhea (range 8–47%), altered consciousness/mental status (range 7–38%), stiff neck (range 7–54%), and nausea (range 7–20%). Sepsis (range 15–83% of cases) was the most commonly reported manifestation followed by meningitis (range 5–72%), sepsis and meningitis (range 6–74%), bacteremic pneumonia (range 4–24%), arthritis (range 1–15%), and other manifestations (e.g., pharyngitis/epiglottitis/supraglottitis/tonsillitis/conjunctivitis; range 1–24%). The case fatality rates ranged from 8–40%, and among the survivors 4–14% had long-term sequelae. Conclusions Clinicians need to be aware of the nonspecific symptoms and signs of IMD, as well as of the atypical manifestations in regions where MenW is known to circulate to ensure timely diagnoses and treatment.